Correlation Between Krystal Biotech and Denali Therapeutics
Can any of the company-specific risk be diversified away by investing in both Krystal Biotech and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krystal Biotech and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krystal Biotech and Denali Therapeutics, you can compare the effects of market volatilities on Krystal Biotech and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krystal Biotech with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krystal Biotech and Denali Therapeutics.
Diversification Opportunities for Krystal Biotech and Denali Therapeutics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Krystal and Denali is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Krystal Biotech and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Krystal Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krystal Biotech are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Krystal Biotech i.e., Krystal Biotech and Denali Therapeutics go up and down completely randomly.
Pair Corralation between Krystal Biotech and Denali Therapeutics
Given the investment horizon of 90 days Krystal Biotech is expected to generate 0.89 times more return on investment than Denali Therapeutics. However, Krystal Biotech is 1.12 times less risky than Denali Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Denali Therapeutics is currently generating about 0.0 per unit of risk. If you would invest 7,846 in Krystal Biotech on October 16, 2024 and sell it today you would earn a total of 7,185 from holding Krystal Biotech or generate 91.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Krystal Biotech vs. Denali Therapeutics
Performance |
| Timeline |
| Krystal Biotech |
| Denali Therapeutics |
Krystal Biotech and Denali Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Krystal Biotech and Denali Therapeutics
The main advantage of trading using opposite Krystal Biotech and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krystal Biotech position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.| Krystal Biotech vs. MeiraGTx Holdings PLC | Krystal Biotech vs. Apellis Pharmaceuticals | Krystal Biotech vs. Regenxbio | Krystal Biotech vs. Rhythm Pharmaceuticals |
| Denali Therapeutics vs. Ginkgo Bioworks Holdings | Denali Therapeutics vs. CureVac NV | Denali Therapeutics vs. Iovance Biotherapeutics | Denali Therapeutics vs. Krystal Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |